NSE · MEDISTEP · Trading
Medistep Healthcare Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹50 Cr with net profit ₹4 Cr — a 8.35% net margin, versus 9.21% the period before.
Shareholding
As of 2026-03-31
- Promoter68.96%
- Public31.04%
514 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.21× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #322 of 666 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,93,459 Cr | 24.35 | 4.83 | 3.42% | 9.3% |
| Avenue Supermarts Limited | ₹2,50,959 Cr | 381.38 | 10.26 | 12.14% | 4.32% |
| Trent Ltd. | ₹1,60,247 Cr | 266.89 | 22.94 | 24.62% | 8.57% |
| FSN E-Commerce Ventures Ltd. | ₹93,790 Cr | 1212.96 | 65.21 | 13.87% | 1.99% |
| Vishal Mega Mart Limited | ₹50,703 Cr | 300.67 | 6.82 | 11.32% | 6.61% |
| Premier Energies Limited | ₹47,038 Cr | 102.19 | 10.91 | 35.05% | 19.3% |
| Aegis Logistics Limited | ₹45,019 Cr | 109.72 | 7.44 | 14.83% | 10.78% |
| Aditya Infotech Limited | ₹40,364 Cr | 238.34 | 21.5 | 19.61% | 8.72% |
| Redington Limited | ₹22,472 Cr | 57.38 | 2.21 | 14.67% | 1.25% |
| Honasa Consumer Limited | ₹14,620 Cr | 210.96 | 10.36 | 14.16% | 8.36% |
| Medistep Healthcare Ltd.(this company) | ₹27 Cr | 4.57 | 0.72 | 15.82% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashMedistep Healthcare Ltd., operating in the Trading sector, has a market capitalization of Rs 28 Cr. The company reported an EPS of 4.21 and a book value of Rs 26.62. Its 52-week high was Rs 53 and its 52-week low was Rs 16.5.
Positives
- +The company's debt-to-equity ratio is low at 0.03.
- +Return on Capital Employed (ROCE) is 19.169%.
- +Promoter holding is substantial at 68.9556% as of March 31, 2026.
- +Promoter shares are not pledged (0%).
Negatives
- −The profit margin is reported as 0%, based on available data.
- −No quarterly results have been disclosed since Jun 2024.
- −Dividend yield is 0%, indicating no dividend distribution.
- −Promoter holding decreased from 93.6242% in Dec 2024 to 68.9556% in Mar 2026.
Financial performance
Medistep Healthcare Ltd. reported an increase in revenue from Rs 31.6252 Cr in Mar 2024 to Rs 49.6585 Cr in Mar 2025. Net profit also rose from Rs 2.9135 Cr in Mar 2024 to Rs 4.1442 Cr in Mar 2025. The EPS increased from 19.96 in Mar 2024 to 4.01 in Mar 2025.
Profitability & returns
The company has a Return on Equity (ROE) of 15.82% and a Return on Capital Employed (ROCE) of 19.169%. The profit margin for the latest annual period was 0%. The PE ratio stands at 4.61.
Balance sheet
Medistep Healthcare Ltd. has a low debt-to-equity ratio of 0.03. The book value per share is Rs 26.62. No dividend yield was reported for the company (0%).
Ownership & pledges
As of March 31, 2026, promoters held 68.9556% of the company's shares. Public shareholding was 31.0444%. There was no promoter pledge reported (0%). The number of shareholders was 514.
Regulatory & surveillance
No specific information regarding regulatory actions or surveillance measures was provided for Medistep Healthcare Ltd.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.